IMPURITIES AVAILABLE FOR 'Befiradol'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Befiradol. Befiradol (also known as F-13640 or NLX-112) is a highly selective and potent full agonist of the serotonin 5-HT₁A receptor, primarily studied for its potential in managing pain and Parkinson’s disease-related dyskinesia. It exerts strong analgesic effects by modulating serotonergic pathways in the central nervous system, offering an alternative to opioid-based pain relief. Befiradol has shown promise in reducing L-DOPA-induced dyskinesia in Parkinson’s patients without compromising motor function. It crosses the blood-brain barrier efficiently and demonstrates a long duration of action. Preclinical studies suggest low risk of dependence and a favorable side effect profile. It is currently under clinical investigation and not yet approved for general medical use. Its novel mechanism makes it a potential candidate for non-opioid pain management and neurological disorders. Buy high quality Befiradol from Omsynth Lifesciences.